Chiral separation in the class of proton pump inhibitors by chromatographic and electromigration techniques: An overview-Reference-Cited by-同舟云学术

Chiral separation in the class of proton pump inhibitors by chromatographic and electromigration techniques: An overview

Published:2021-05-27 Issue:17-18 Volume:42 Page:1761-1789
ISSN:0173-0835
Container-title:ELECTROPHORESIS
language:en
Short-container-title:ELECTROPHORESIS

Author:

Papp Lajos Attila¹^ORCID,Hancu Gabriel¹^ORCID,Kelemen Hajnal¹,Tóth Gergő²^ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry “George Emil Palade” University of Medicine, Pharmacy, Sciences and Technology of Târgu Mureș Romania

2. Department of Pharmaceutical Chemistry Semmelweis University Budapest Hungary

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/elps.202100032

Reference153 articles.

1. Optical Isomerism in Drugs

2. Putting chirality to work: the strategy of chiral switches

3. The predicated demise of racemic new molecular entities is an exaggeration

4. The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds

5. U. S. Food and Drug Administration (FDA) CDER New Drugs at FDA: CDER's New Molecular Entities and New Therapeutic Biological Products https://www.fda.gov/drugs/development‐approval‐process‐drugs/newdrugs‐fda‐cders‐new‐molecular‐entities‐and‐new‐therapeutic‐biological‐products[accessed Jan 20 2021].

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sorting of enantiomers using optical chirality in uniform light field;Applied Physics Letters;2024-05-06

2. Development and application of a supercritical fluid chromatography-tandem mass spectrometry method for the simultaneous determination of pantoprazole enantiomers in rat plasma;Journal of Pharmaceutical and Biomedical Analysis Open;2023-12

3. Sulfoxides in medicine;Current Opinion in Chemical Biology;2023-10

4. Formulation of Dosage Forms with Proton Pump Inhibitors: State of the Art, Challenges and Future Perspectives;Pharmaceutics;2022-09-25

5. Pump proton inhibitors display anti‐tumour potential in glioma;Cell Proliferation;2022-08-12